ADMA Biologics Inc (ADMA)
17.41
-0.31
(-1.75%)
USD |
NASDAQ |
Dec 24, 16:00
ADMA Biologics Cash from Investing (Quarterly): -1.098M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics Inc | -44.04M |
| Alnylam Pharmaceuticals Inc | -30.25M |
| Catalyst Pharmaceuticals Inc | -0.259M |
| Sarepta Therapeutics Inc | -128.82M |
| Krystal Biotech Inc | -34.33M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 25.03M |
| Cash from Financing (Quarterly) | -25.47M |
| Free Cash Flow | 78.82M |
| Free Cash Flow Per Share (Quarterly) | 0.0978 |
| Free Cash Flow to Equity (Quarterly) | 53.68M |
| Free Cash Flow to Firm (Quarterly) | 26.70M |
| Free Cash Flow Yield | 1.91% |